Spyros Charonis

1.0k total citations · 1 hit paper
15 papers, 671 citations indexed

About

Spyros Charonis is a scholar working on Molecular Biology, Infectious Diseases and Immunology. According to data from OpenAlex, Spyros Charonis has authored 15 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Immunology. Recurrent topics in Spyros Charonis's work include vaccines and immunoinformatics approaches (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Immunotherapy and Immune Responses (5 papers). Spyros Charonis is often cited by papers focused on vaccines and immunoinformatics approaches (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Immunotherapy and Immune Responses (5 papers). Spyros Charonis collaborates with scholars based in United States, United Kingdom and Greece. Spyros Charonis's co-authors include Jim Warwicker, Robin Curtis, Max Hebditch, Apostolos P. Georgopoulos, Lisa M. James, Constantinos A. Demopoulos, Aristidis Charonis, Elizabeth Fragopoulou, Effie C. Tsilibary and G. Drossopoulou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and Scientific Reports.

In The Last Decade

Spyros Charonis

15 papers receiving 663 citations

Hit Papers

Protein–Sol: a web tool for predicting protein solubility... 2017 2026 2020 2023 2017 100 200 300 400 500

Peers

Spyros Charonis
Zahra Khedri United States
Vaibhav Upadhyay United States
Douglas Fox United States
Scott Winston United States
Spyros Charonis
Citations per year, relative to Spyros Charonis Spyros Charonis (= 1×) peers Willem A. de Jongh

Countries citing papers authored by Spyros Charonis

Since Specialization
Citations

This map shows the geographic impact of Spyros Charonis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spyros Charonis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spyros Charonis more than expected).

Fields of papers citing papers by Spyros Charonis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spyros Charonis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spyros Charonis. The network helps show where Spyros Charonis may publish in the future.

Co-authorship network of co-authors of Spyros Charonis

This figure shows the co-authorship network connecting the top 25 collaborators of Spyros Charonis. A scholar is included among the top collaborators of Spyros Charonis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spyros Charonis. Spyros Charonis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Georgopoulos, Apostolos P., Lisa M. James, Spyros Charonis, & Matthew J. Sanders. (2023). Melanoma and Human Leukocyte Antigen (HLA): Immunogenicity of 69 HLA Class I Alleles With 11 Antigens Expressed in Melanoma Tumors. Cancer Informatics. 22. 2673799164–2673799164. 3 indexed citations
2.
James, Lisa M., Spyros Charonis, & Apostolos P. Georgopoulos. (2023). Schizophrenia, Human Leukocyte Antigen (HLA), and Herpes Viruses: Immunogenetic Associations at the Population Level. SHILAP Revista de lepidopterología. 18. 2308794315–2308794315. 2 indexed citations
3.
Charonis, Spyros, Lisa M. James, & Apostolos P. Georgopoulos. (2022). SARS-CoV-2 in silico binding affinity to human leukocyte antigen (HLA) Class II molecules predicts vaccine effectiveness across variants of concern (VOC). Scientific Reports. 12(1). 8074–8074. 10 indexed citations
4.
Charonis, Spyros, et al.. (2021). In silico investigation of binding affinities between human leukocyte antigen class I molecules and SARS-CoV-2 virus spike and ORF1ab proteins. SHILAP Revista de lepidopterología. 1. 16–26. 5 indexed citations
5.
James, Lisa M., Spyros Charonis, & Apostolos P. Georgopoulos. (2021). Association of Dementia Human Leukocyte Antigen (HLA) Profile with Human Herpes Viruses 3 and 7: An in-silico Investigation. PubMed. 5(3). 7–14. 5 indexed citations
7.
Charonis, Spyros, et al.. (2021). Vaccines for Influenza. Vaccines. 9(1). 47–47. 8 indexed citations
8.
Charonis, Spyros, Lisa M. James, & Apostolos P. Georgopoulos. (2020). In silico assessment of binding affinities of three dementia-protective Human Leukocyte Antigen (HLA) alleles to nine human herpes virus antigens. Current Research in Translational Medicine. 68(4). 211–216. 14 indexed citations
9.
James, Lisa M., et al.. (2020). Commentary: COVID-19 and the Path to Immunity. PubMed. 4(4). 31–33. 2 indexed citations
10.
Charonis, Spyros, Lisa M. James, & Apostolos P. Georgopoulos. (2020). <i>In Silico</i> Assessment of Binding Affinities of Three Dementia-Protective Human Leukocyte Antigen (HLA) Alleles to Nine Human Herpes Virus Antigens. SSRN Electronic Journal. 3 indexed citations
12.
13.
Hebditch, Max, et al.. (2017). Protein–Sol: a web tool for predicting protein solubility from sequence. Bioinformatics. 33(19). 3098–3100. 527 indexed citations breakdown →
14.
Warwicker, Jim, Spyros Charonis, & Robin Curtis. (2013). Lysine and Arginine Content of Proteins: Computational Analysis Suggests a New Tool for Solubility Design. Molecular Pharmaceutics. 11(1). 294–303. 58 indexed citations
15.
Tsilibary, Effie C., Elizabeth Fragopoulou, Christos Iatrou, et al.. (2013). Vitamin D Receptor Activators Upregulate and Rescue Podocalyxin Expression in High Glucose-Treated Human Podocytes. Nephron Experimental Nephrology. 122(1-2). 36–50. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026